APA (7th ed.) Citation

JA, S., M, C., RJ, G., G, T., J, H., FL, B., . . . SM, S. (2024). Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival. NEJM evidence, 3(8), EVIDoa2300267. https://doi.org/10.1056/EVIDoa2300267

Chicago Style (17th ed.) Citation

JA, Sparano, et al. "Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival." NEJM Evidence 3, no. 8 (2024): EVIDoa2300267. https://doi.org/10.1056/EVIDoa2300267.

MLA (9th ed.) Citation

JA, Sparano, et al. "Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival." NEJM Evidence, vol. 3, no. 8, 2024, p. EVIDoa2300267, https://doi.org/10.1056/EVIDoa2300267.